Husky Injection Molding Systems has entered into a definitive agreement to acquire medical and closure moldmaker Schöttli Group of Diessenhofen, Switzerland.

Husky Injection Molding Systems has entered into a definitive agreement to acquire medical and closure moldmaker Schöttli Group of Diessenhofen, Switzerland. The sale is expected to close in early December.

Husky says the acquisition will provide its hot runner customers with product improvements based on strengthened knowledge and will give existing Schöttli customers more streamlined access to Husky’s hot runner, controller and injection molding machine products. In addition, Schöttli’s closures business is expected to complement Husky’s by providing additional technology and capacity in both established and growing markets.

“Husky has enjoyed a strong and long-lasting relationship with Schöttli and we have long shared a mutual commitment to quality, technology innovation and customer satisfaction,” says John Galt, Husky’s president and CEO. “Through this acquisition, we will be able to work with the many skilled people at Schöttli as one team to deliver more value to customers, particularly in the medical and closures markets. Our goal is to expand our knowledge, expertise, capacity and global footprint so that we can provide the best possible support to customers in these areas of our business.”

Once the sale closes, Schöttli’s Swiss headquarters as well as other facilities in San Dimas, California, and Suzhou, China, will become part of Husky’s global network of locations.